Generic medicines face no tariffs, though the Trump administration reserves the right to revisit that in the future. Some branded drugmakers face a reduced tariff rate, but that could change if they don’t reach a so-called most-favored nation drug price deal.
The post The Drug Companies Avoiding Trump’s Tariffs — For Now appeared first on MedCity News.
